An Official Website of the United States Government
Field Deployable Diagnostic Test for Active Cutaneous Leishmania and a Test for…
- Small Business Information
-
Woman-Owned: NoMinority-Owned: YesHUBZone-Owned: No
- Phase 1
-
Fiscal Year: 2005Title: Field Deployable Diagnostic Test for Active Cutaneous Leishmania and a Test for Latent InfectionAgency / Branch: DOD / ARMYContract: W81XWH-05-C-0020Award Amount: $69,999.00
Abstract:
Leishmaniasis has significant impact on military and civilian populations throughout the Asia-Africa region, including Afghanistan and Iraq. There are currrentlly no proper field-deployable diagnostic tools for the key form, cutaneous leishmaniasis. Development of an assay which detects cutaneous leishmaniasis, that is rapid, accurate, field usable, soldier-friendly, and meets regulatory requirements is a high priority for DoD and also a priority for health and government medical centers responsible for inhabitants and visitors to the region. Access Bio proposes to develop and commercialize a rapid diagnostic test for military and civilian use. Immediate benefits include the ability to detect cutaneous leishmaniasis on a disease-stage basis (acute/chronic) and generation of revenues to a US small business concern. Downstream potential benefits include utilization of the knowledge to develop a useful monitoring kit for a leishmaniasis vaccine currently under development and application and modification of the current research and development approach to other parasitic diseases in the future.Small Business Information at Submission:ACCESS BIO, INC.
2033 Route 130 Monmouth Jct., NJ 08852EIN/Tax ID: 460505083DUNS: N/ANumber of Employees:Woman-Owned: NoMinority-Owned: NoHUBZone-Owned: No
Award Information
|
Agency: Department of Defense |
Branch: Army |
Award ID: 73694 |
Program Year/Program: 2005 / SBIR |
|
Agency Tracking Number: A043-177-1132 |
Solicitation Year: N/A |
Solicitation Topic Code: N/A |
Solicitation Number: N/A |